MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and ...

AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra's obesity drug. AI takes center stage at HIMSS ...

Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.

The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.

WESH 2's Jason Guy and Orlando Health Weight Loss & Bariatric Surgery Institute surgeon, Dr. Muhammad Ghanem, discuss potential influences on the downward trend ...

Rutgers University recently launched the Center for NeuroMetabolism, which aims to address the weight loss and health ...

A leading A&E doctor has warned about the dangers of weight loss jabs after an investigation found a major high street ...

While some drugs have fallen off, more have been added: AbbVie recently jumped into the obesity craze by licensing an ...

The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability ...

I thought I was about to make a new mum friend at the school gate. But then I was asked if I wanted to join the 'sema gang'.

Most obese patients grow resistant to satiety signals from the hormone leptin. A new study shows that leptin sensitivity can be restored in mice, leading to weight loss.

Commercial insurance coverage of blockbuster GLP-1 drugs has not expanded much over the past year, despite growing demand and expanded indications, according to a new report from GoodRx. Data from ...